- Home
- ARKO vs FDMT Comparison
ARKO vs FDMT Comparison
Compare ARKO & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARKO | FDMT |
|---|---|---|
| Founded | 1970 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 523.7M | 513.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | ARKO | FDMT |
|---|---|---|
| Price | $6.26 | $8.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $7.50 | ★ $34.13 |
| AVG Volume (30 Days) | 571.5K | ★ 766.3K |
| Earning Date | 01-01-0001 | 04-13-2026 |
| Dividend Yield | ★ 1.88% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $37,000.00 |
| Revenue This Year | $13.58 | $21,227.03 |
| Revenue Next Year | N/A | $161.87 |
| P/E Ratio | $56.88 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.51 | $2.24 |
| 52 Week High | $6.71 | $12.34 |
Technical Indicators
Market Signals| Indicator | ARKO | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 57.30 | 44.29 |
| Support Level | $3.94 | $8.11 |
| Resistance Level | $6.71 | $8.80 |
| Average True Range (ATR) | 0.27 | 0.57 |
| MACD | -0.03 | -0.12 |
| Stochastic Oscillator | 58.23 | 11.49 |
Price Performance
Historical ComparisonAbout ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.